You have no items in your shopping cart.
Troubleshooting & Specificity
Non-Specific Binding & Blocking Peptides
Confirm antibody specificity in Western blot and IHC using immunizing peptide competition controls.
On Western blots or immunohistochemistry (IHC) tissue sections, researchers sometimes observe non-specific binding of an antibody to off-target proteins.
In Western blotting, this non-specific interaction presents as multiple unexpected bands rather than the expected single or double bands at the predicted molecular weight. In IHC, it creates diffuse, high-background staining. While non-specific binding occurs more frequently with polyclonal antibodies due to their multi-epitope nature, it can also manifest in monoclonal antibodies under certain experimental conditions.
When unexpected bands or staining patterns appear, identifying which signal corresponds specifically to your target protein is crucial. Performing an immunizing peptide blocking experiment (peptide competition assay) provides a reliable control to confirm target specificity.
1. How Blocking Peptides Work
Before running your primary staining protocol, the antibody is neutralized by pre-incubating it with an excess of the synthetic peptide corresponding to the specific epitope recognized by the antibody. These molecules are known as blocking (or immunizing) peptides.
The Mechanism of Neutralization
When pre-incubated together, the antibody's antigen-binding sites (Fab regions) become saturated by the free immunizing peptide. Consequently, the neutral-bound antibody is no longer available to bind to its target epitope on the Western blot membrane or tissue section.
By comparing the signal from the blocked antibody directly alongside the signal from the antibody alone (run in parallel under identical conditions), you can easily distinguish specific target binding from off-target background:
- Specific Target Signal: Bands or cellular staining present in the control lane but completely absent or significantly reduced in the peptide-blocked lane confirm specific target recognition.
- Non-Specific Background: Any persistent bands or tissue staining that remain unchanged despite peptide pre-incubation represent non-specific binding to off-target proteins or assay matrix components.
2. Step-by-Step Competition Protocol
Follow this streamlined workflow to conduct a peptide blocking control assay in your laboratory:
Calculate Peptide Excess
Prepare two identical tubes of primary antibody at your working dilution. Add a 5-fold to 10-fold molar excess (typically a 1:1 to 1:5 mass ratio, e.g., 1 μg antibody to 5 μg peptide) of immunizing peptide to Tube A. Add an equal volume of incubation buffer alone to Tube B (antibody-only control).
Pre-Incubate Antibody & Peptide
Incubate both Tube A (neutralized) and Tube B (control) for 30–60 minutes at room temperature, or overnight at 4°C, with gentle agitation to allow complete antibody-peptide complex formation.
Parallel Assay Execution
Apply Tube A and Tube B to separate, identical membrane lanes (WB) or tissue sections (IHC). Proceed with your standard primary incubation, wash steps, secondary antibody detection, and imaging under identical exposure settings.
Need the Complete Technical Protocol?
Access Biorbyt's step-by-step protocol for optimizing peptide concentration, incubation times, and buffer selection.
Read the Protocol Guide3. Modern Validation Standards & Recommendations
While peptide competition assays effectively verify that an antibody binds its immunogen sequence, modern validation guidelines (including the 5 Pillars of Antibody Validation) recommend combining peptide blocking with genetic or orthogonal controls for definitive validation:
- Peptide Blocking Scope: Confirms sequence-specific binding to the immunogen, helping eliminate cross-reactivity concerns between similar protein isoforms sharing partial sequence homology.
- Complementary Genetic Validation: Combining peptide competition with Knockout (KO) or Knockdown (KD) controls provides double confirmation, verifying both antibody specificity and physical absence of target signal in genetic null models.
- Scrambled Control Peptides: For rigorous quantitative studies, using a scrambled version of the immunogen peptide as a secondary negative control helps rule out non-specific protein-protein interference caused by high peptide concentrations in solution.
4. Popular Matched Antibody & Peptide Pairs
Selecting a pre-validated antibody and immunizing peptide pair ensures exact sequence alignment and reliable competition results. Explore Biorbyt's most popular matched pairs below:
CD133 Matched Pair
EGFP Matched Pair
| Catalog # | Description |
|---|---|
| orb195989 | Rabbit polyclonal antibody to EGFP |
| orb1984503 | EGFP Blocking Peptide |
CD31 Matched Pair
PGC1 Alpha Matched Pair
| Catalog # | Description |
|---|---|
| orb13647 | Rabbit polyclonal antibody to PGC1 alpha |
| orb374773 | PGC1 alpha Blocking Peptide |